GEN Exclusives

More »

GEN News Highlights

More »
Jun 1, 2007

BMS Signs Research Services Agreement with Immunicon for Oncology Biomarker Development

  • Immunicon entered into a research services agreement with Bristol-Myers Squibb involving protein and molecular targets associated with circulating tumor cells.

    “Our collaborations span across protein biomarkers, phosphoproteins, and a variety of FISH assays to study gene amplification in a number of different carcinomas. We believe that our development work will advance the understanding of cancer biology as well as accelerate the time to market for promising new drugs,” comments Leon Terstappen, M.D., Ph.D., CSO at Immunicon.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?